Cargando…

A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy

Detalles Bibliográficos
Autores principales:	Martin, Fabiola, Castro, Hannah, Gabriel, Carolyn, Adonis, Adine, Fedina, Alexandra, Harrison, Linda, Brodnicki, Liz, Demontis, Maria A, Babiker, Abdel G, Weber, Jonathan N, Bangham, Charles RM, Taylor, Graham P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044352/ http://dx.doi.org/10.1186/1742-4690-11-S1-P31

Ejemplares similares

Ciclosporin A Proof of Concept Study in Patients with Active, Progressive HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
por: Martin, Fabiola, et al.
Publicado: (2012)

Treatment of patients with HTLV-1-associated myelopathy with methotrexate
por: Ahmed, S, et al.
Publicado: (2014)

Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy
por: Buell, Kevin G., et al.
Publicado: (2016)

Comparison of walking measures in patients with HTLV-1 Associated Myelopathy
por: Adonis, Adine, et al.
Publicado: (2015)

Assessing Walking Ability in People with HTLV-1-Associated Myelopathy Using the 10 Meter Timed Walk and the 6 Minute Walk Test
por: Adonis, Adine, et al.
Publicado: (2016)

Effect of pulsed methylprednisolone on disease severity, viral load and inflammation in patients with human T-lymphotropic virus type 1 associated myelopathy
por: Buell, Kevin, et al.
Publicado: (2015)

Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility study
por: Martin, Fabiola, et al.
Publicado: (2015)

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Kirk, Paul DW, et al.
Publicado: (2011)

Using the 6 minute walk to investigate endurance in patients with HTLV associated myelopathy
por: Adonis, A, et al.
Publicado: (2014)

The HTLV-1 Virological Synapse
por: Nejmeddine, Mohamed, et al.
Publicado: (2010)

Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial
por: Taylor, Graham P, et al.
Publicado: (2006)

HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection
por: Bangham, Charles R.M., et al.
Publicado: (2014)

Three plasma biomarkers of HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Kirk, Paul, et al.
Publicado: (2011)

Susceptibility of Primary HTLV-1 Isolates from Patients with HTLV-1-Associated Myelopathy to Reverse Transcriptase Inhibitors
por: Macchi, Beatrice, et al.
Publicado: (2011)

Host determinants of HTLV-1 integration site preference
por: McCallin, Amy J, et al.
Publicado: (2015)

Absence of HTLV‐II Co‐infection in HTLV‐I‐associated Myelopathy Patients
por: Miyamoto, Kanji, et al.
Publicado: (1992)

Systems Biology Approaches Reveal a Specific Interferon-Inducible Signature in HTLV-1 Associated Myelopathy
por: Tattermusch, Sonja, et al.
Publicado: (2012)

CD25+CCR4+ cells as a marker of HTLV-1-infected cells in peripheral blood
por: Kagdi, Huseini, et al.
Publicado: (2014)

Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic
por: Matsuzaki, Toshio, et al.
Publicado: (2014)

HTLV-1-associated infective dermatitis and probable HTLV-1- associated myelopathy in an adolescent female
por: Steglich, Raquel Bisacotti, et al.
Publicado: (2015)

Clonality of HTLV-1 differs between infected CD8+ T cells and infected CD4+ T cells in vivo
por: Melamed, Anat, et al.
Publicado: (2014)

Aquaporin-4 Antibodies Are Not Related to HTLV-1 Associated Myelopathy
por: von Glehn, Felipe, et al.
Publicado: (2012)

Cardiovascular risk profile in patients with myelopathy associated with HTLV-1()
por: Prado, Fabio Luís Silva do, et al.
Publicado: (2017)

Clonality of HTLV-2 in natural infection
por: Melamed, Anat, et al.
Publicado: (2014)

Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Burbelo, Peter D, et al.
Publicado: (2008)

HTLV-1 infection: role of CTL efficiency
por: Bangham, Charles R. M.
Publicado: (2008)

Tumor suppressor in lung cancer identifies latency infected cells in non malignant HTLV-1 infection
por: Manivannan, Kiruthika, et al.
Publicado: (2015)

Epigenetic changes around the pX region and spontaneous HTLV-1 transcription are CTCF-independent
por: Miura, Michi, et al.
Publicado: (2018)

The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Rafatpanah, Houshang, et al.
Publicado: (2013)

Conference highlights of the 15th international conference on human retrovirology: HTLV and related retroviruses, 4-8 june 2011, Leuven, Gembloux, Belgium
por: Martin, Fabiola, et al.
Publicado: (2011)

Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy
por: Perzova, Raisa, et al.
Publicado: (2013)

Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2014)

Median Nerve Somatosensory Evoked Potential in HTLV-I Associated Myelopathy
por: Boostani, Reza, et al.
Publicado: (2016)

Early-Onset HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Schwalb, Alvaro, et al.
Publicado: (2020)

Balance assessment in HTLV-1 associated myelopathy or tropical spastic paraparesis
por: Patrício, Naiane Araújo, et al.
Publicado: (2020)

Diffusion tensor imaging metrics in diagnosis of HTLV‐1‐associated myelopathy
por: Liberato de Matos, Sheila N. F., et al.
Publicado: (2022)

Estimating rates of de novo infection and mitotic replication in HTLV-1 persistence: de novo infection continues after early infection
por: Laydon, Daniel J, et al.
Publicado: (2015)

HTLV-1 inserts an ectopic CTCF-binding site into the human genome
por: Satou, Yorifumi, et al.
Publicado: (2015)

Health state utility values in people living with HTLV-1 and in patients with HAM/TSP: The impact of a neglected disease on the quality of life
por: Rosadas, Carolina, et al.
Publicado: (2020)

Amendment on brain signal intensity on Magnetic Resonance Imaging of asymptomatic HTLV-1 seropositive and HTLV-1 associated myelopathy
por: Bastos, Rafael HC, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7poo5ee9atdbb91hifpfu93g1u